Chargement en cours...
Review and Management of Drug Interactions with Boceprevir and Telaprevir
Boceprevir and telaprevir, when added to pegylated interferon and ribavirin for the treatment of chronic hepatitis C virus infection, increase the rates of sustained virologic response in treatment naïve persons to approximately 70%. While these agents represent an important advance in the treatment...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3345276/ https://ncbi.nlm.nih.gov/pubmed/22331658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.25653 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|